Dan Williams

Dan Williams is a highly accomplished executive with a diverse background in the biotechnology and pharmaceutical industry.

He obtained his PhD from The University of Dundee, showcasing his strong academic foundation.

Currently, Dan serves as the Chief Executive Officer at SynaptixBio Ltd., where he leads strategic decision-making and operations.

Previously, he founded and directed Danes Consultants Ltd., demonstrating his entrepreneurial spirit and leadership skills.

Prior to his current role, Dan held various key positions at Adaptimmune, including VP roles in Research and Technology Operations, Pipeline Operations, and Research Operations and Portfolio Management.

His extensive experience also includes roles as Director of Research and Programme Management, Head of Translational Development, and Associate Director of Translational Development at Adaptimmune.

Before his time at Adaptimmune, Dan Williams contributed his expertise to companies like Meatable BV, ImmunoCore, Medigene Ltd., and Avidex Ltd.

His career progression showcases a commitment to innovation, research, and strategic management within the biopharmaceutical sector.

With a track record of success in various leadership roles, Dan combines scientific knowledge with business acumen to drive organizational growth and development.